---
figid: PMC6002979__13045_2018_621_Fig1_HTML
figtitle: B cell receptor signaling pathway
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6002979
filename: 13045_2018_621_Fig1_HTML.jpg
figlink: /pmc/articles/PMC6002979/figure/Fig1/
number: F1
caption: B cell receptor signaling pathway with receptors, inhibitors, targets, and
  other molecules. B cell receptor signaling mediates the canonical pathway for nuclear
  translocation of the transcription factor NF-κB. Initial activation of the B cell
  receptor activates Src family kinases and the Syk and Btk tyrosine kinases, which
  form a signalosome complex with other signaling enzymes and proteins. Btk phosphorylates
  and activates PLCγ2, which yields the downstream molecules inositol-1,4,5-triphosphate
  (IP3) and diacylglycerol (DAG) and sensitizes PKCβ due to release of calcium ions.
  The activated PKC leads to formation of the CBM complex; the IKK complex is then
  activated, which phosphorylates IκB, allowing it to be ubiquitinated and proteasomally
  degraded. The p50 and p65-RelA NF-κB heterodimer is then released into the nucleus
  to induce gene expression
papertitle: NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
reftext: Swathi Balaji, et al. J Hematol Oncol. 2018;11:83.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9570255
figid_alias: PMC6002979__F1
figtype: Figure
redirect_from: /figures/PMC6002979__F1
ndex: 6ad050a9-dee7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6002979__13045_2018_621_Fig1_HTML.html
  '@type': Dataset
  description: B cell receptor signaling pathway with receptors, inhibitors, targets,
    and other molecules. B cell receptor signaling mediates the canonical pathway
    for nuclear translocation of the transcription factor NF-κB. Initial activation
    of the B cell receptor activates Src family kinases and the Syk and Btk tyrosine
    kinases, which form a signalosome complex with other signaling enzymes and proteins.
    Btk phosphorylates and activates PLCγ2, which yields the downstream molecules
    inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG) and sensitizes PKCβ
    due to release of calcium ions. The activated PKC leads to formation of the CBM
    complex; the IKK complex is then activated, which phosphorylates IκB, allowing
    it to be ubiquitinated and proteasomally degraded. The p50 and p65-RelA NF-κB
    heterodimer is then released into the nucleus to induce gene expression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd19
  - Tnfsf13b
  - Cd40lg
  - Trem2
  - Cd40
  - Tyrobp
  - Bcr
  - Pik3r1
  - Lyn
  - Syk
  - Akt1
  - Mtor
  - Btk
  - Blnk
  - Hspg2
  - Map4k4
  - Map3k14
  - ras
  - Hras
  - Kras
  - Rem1
  - Prkcb
  - Card11
  - Ephb2
  - Mapk1
  - Traf6
  - lt
  - Bcl10
  - Chuk
  - Nfkbib
  - Nr2c2
  - Map3k7
  - Apk
  - Ikbkb
  - Nfkb1
  - Agrp
  - Art2b
  - Dclre1c
  - CD19
  - TNFSF13B
  - CD40LG
  - TREM2
  - CD40
  - TYROBP
  - BCR
  - RN7SL263P
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LYN
  - SYK
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - BTK
  - BLNK
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - MAP3K14
  - MAP4K4
  - KRAS
  - HRAS
  - NRAS
  - PRKCB
  - CARD11
  - EPHB2
  - MAPK1
  - MAPK3
  - TRAF6
  - BCL10
  - CHUK
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - MAP3K7
  - NR2C2
  - IKBKB
  - NFKB1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - AGRP
  - ARTN
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - mol
  - RhoGAP1A
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Shark
  - Akt
  - Tor
  - norpA
  - sl
  - Plc21C
  - Ni-K
  - msn
  - Ras64B
  - Ras85D
  - Erk7
  - rl
  - E(spl)malpha-BFM
  - Tak1
  - Nplp1
  - IKKbeta
  - Dif
  - dl
  - Rel
  - NFAT
  - art
  - Dll
  - md
  - E(spl)mdelta-HLH
  - ca
  - MKP-4
  - p38b
  - Bortezomib
  - Carbizomib
  - Marizomib
  - MLN9708
  - Ixazomib
  - Ibrutinib
  - ITAM
  - MD Anderson Cancer
---
